Literature DB >> 21421848

Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid.

Rodolphe Dusaulcy1, Chloé Rancoule, Sandra Grès, Estelle Wanecq, André Colom, Charlotte Guigné, Laurens A van Meeteren, Wouter H Moolenaar, Philippe Valet, Jean Sébastien Saulnier-Blache.   

Abstract

Autotaxin (ATX) is a secreted lysophospholipase D that generates the lipid mediator lysophosphatidic acid (LPA). ATX is secreted by adipose tissue and its expression is enhanced in obese/insulin-resistant individuals. Here, we analyzed the specific contribution of adipose-ATX to fat expansion associated with nutritional obesity and its consequences on plasma LPA levels. We established ATX(F/F)/aP2-Cre (FATX-KO) transgenic mice carrying a null ATX allele specifically in adipose tissue. FATX-KO mice and their control littermates were fed either a normal or a high-fat diet (HFD) (45% fat) for 13 weeks. FATX-KO mice showed a strong decrease (up to 90%) in ATX expression in white and brown adipose tissue, but not in other ATX-expressing organs. This was associated with a 38% reduction in plasma LPA levels. When fed an HFD, FATX-KO mice showed a higher fat mass and a higher adipocyte size than control mice although food intake was unchanged. This was associated with increased expression of peroxisome proliferator-activated receptor (PPAR)γ2 and of PPAR-sensitive genes (aP2, adiponectin, leptin, glut-1) in subcutaneous white adipose tissue, as well as in an increased tolerance to glucose. These results show that adipose-ATX is a negative regulator of fat mass expansion in response to an HFD and contributes to plasma LPA levels.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21421848      PMCID: PMC3090245          DOI: 10.1194/jlr.M014985

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  22 in total

1.  Targeted expression of Cre recombinase to adipose tissue of transgenic mice directs adipose-specific excision of loxP-flanked gene segments.

Authors:  C Barlow; M Schroeder; J Lekstrom-Himes; H Kylefjord; C X Deng; A Wynshaw-Boris; B M Spiegelman; K G Xanthopoulos
Journal:  Nucleic Acids Res       Date:  1997-06-15       Impact factor: 16.971

2.  Secretion of a lysophospholipase D activity by adipocytes: involvement in lysophosphatidic acid synthesis.

Authors:  Stéphane Gesta; Marie-Françoise Simon; Astrid Rey; David Sibrac; Alexia Girard; Max Lafontan; Philippe Valet; Jean Sébastien Saulnier-Blache
Journal:  J Lipid Res       Date:  2002-06       Impact factor: 5.922

3.  Identification of a potent adipocyte-specific enhancer: involvement of an NF-1-like factor.

Authors:  R A Graves; P Tontonoz; S R Ross; B M Spiegelman
Journal:  Genes Dev       Date:  1991-03       Impact factor: 11.361

4.  Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression.

Authors:  J Boucher; D Quilliot; J P Pradères; M F Simon; S Grès; C Guigné; D Prévot; G Ferry; J A Boutin; C Carpéné; P Valet; J S Saulnier-Blache
Journal:  Diabetologia       Date:  2005-02-08       Impact factor: 10.122

5.  Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity.

Authors:  Gilles Ferry; Edwige Tellier; Anne Try; Sandra Grés; Isabelle Naime; Marie Françoise Simon; Marianne Rodriguez; Jérémie Boucher; Ivan Tack; Stéphane Gesta; Pascale Chomarat; Marc Dieu; Martine Raes; Jean Pierre Galizzi; Philippe Valet; Jean A Boutin; Jean Sébastien Saulnier-Blache
Journal:  J Biol Chem       Date:  2003-03-17       Impact factor: 5.157

6.  Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle.

Authors:  Weimin He; Yaacov Barak; Andrea Hevener; Peter Olson; Debbie Liao; Jamie Le; Michael Nelson; Estelita Ong; Jerrold M Olefsky; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-05       Impact factor: 11.205

7.  Adipose tissue-derived tumor necrosis factor activity correlates with fat cell size but not insulin action in aging rats.

Authors:  C L Morin; E C Gayles; D A Podolin; Y Wei; M Xu; M J Pagliassotti
Journal:  Endocrinology       Date:  1998-12       Impact factor: 4.736

8.  Depot-specific differences in adipogenic progenitor abundance and proliferative response to high-fat diet.

Authors:  Aaron W B Joe; Lin Yi; Yasmine Even; A Wayne Vogl; Fabio M V Rossi
Journal:  Stem Cells       Date:  2009-10       Impact factor: 6.277

Review 9.  Peroxisome proliferator-activated receptor gamma and cardiovascular diseases.

Authors:  Hiroyuki Takano; Issei Komuro
Journal:  Circ J       Date:  2009-01-08       Impact factor: 2.993

Review 10.  Autotaxin.

Authors:  Jean A Boutin; Gilles Ferry
Journal:  Cell Mol Life Sci       Date:  2009-06-09       Impact factor: 9.261

View more
  74 in total

Review 1.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

2.  Depot-specific regulation of autotaxin with obesity in human adipose tissue.

Authors:  Chloé Rancoule; Rodolphe Dusaulcy; Karine Tréguer; Sandra Grès; Charlotte Guigné; Didier Quilliot; Philippe Valet; Jean Sébastien Saulnier-Blache
Journal:  J Physiol Biochem       Date:  2012-05-27       Impact factor: 4.158

Review 3.  Intestinal phospholipid and lysophospholipid metabolism in cardiometabolic disease.

Authors:  David Y Hui
Journal:  Curr Opin Lipidol       Date:  2016-10       Impact factor: 4.776

4.  An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.

Authors:  Flavia V Castelino; Gretchen Bain; Veronica A Pace; Katharine E Black; Leaya George; Clemens K Probst; Lance Goulet; Robert Lafyatis; Andrew M Tager
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

Review 5.  Lysophospholipids in coronary artery and chronic ischemic heart disease.

Authors:  Ahmed Abdel-Latif; Paula M Heron; Andrew J Morris; Susan S Smyth
Journal:  Curr Opin Lipidol       Date:  2015-10       Impact factor: 4.776

6.  Tomatoes, lysophosphatidic acid, and the small intestine: new pieces in the puzzle of apolipoprotein mimetic peptides?

Authors:  A T Remaley
Journal:  J Lipid Res       Date:  2013-10-21       Impact factor: 5.922

7.  Allergic to autotaxin. A new role for lysophospholipase d and lysophosphatidic Acid in asthma?

Authors:  Steve N Georas
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

8.  Metabolite Signatures of Metabolic Risk Factors and their Longitudinal Changes.

Authors:  Xiaoyan Yin; Subha Subramanian; Christine M Willinger; George Chen; Peter Juhasz; Paul Courchesne; Brian H Chen; Xiaohang Li; Shih-Jen Hwang; Caroline S Fox; Christopher J O'Donnell; Pieter Muntendam; Valentin Fuster; Ivana Bobeldijk-Pastorova; Silvia C Sookoian; Carlos J Pirola; Neal Gordon; Aram Adourian; Martin G Larson; Daniel Levy
Journal:  J Clin Endocrinol Metab       Date:  2016-02-23       Impact factor: 5.958

9.  Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism.

Authors:  Kenneth D'Souza; Carine Nzirorera; Andrew M Cowie; Geena P Varghese; Purvi Trivedi; Thomas O Eichmann; Dipsikha Biswas; Mohamed Touaibia; Andrew J Morris; Vassilis Aidinis; Daniel A Kane; Thomas Pulinilkunnil; Petra C Kienesberger
Journal:  J Lipid Res       Date:  2018-08-02       Impact factor: 5.922

10.  Adipose Tissue Lipokines: Recent Progress and Future Directions.

Authors:  Veronica L Li; Joon T Kim; Jonathan Z Long
Journal:  Diabetes       Date:  2020-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.